R Wesley Vosburg, Abdelrahman Nimeri, Dan Azagury, Brandon Grover, Sabrena Noria, Pavlos Papasavas, Jonathan Carter
{"title":"关于代谢和减肥手术后边缘溃疡治疗的 ASMBS 文献综述。","authors":"R Wesley Vosburg, Abdelrahman Nimeri, Dan Azagury, Brandon Grover, Sabrena Noria, Pavlos Papasavas, Jonathan Carter","doi":"10.1016/j.soard.2024.10.003","DOIUrl":null,"url":null,"abstract":"<p><p>Marginal ulcers (MUs) encompass a group of mucosal disruptions and subsequent inflammatory changes and their sequala found after Roux-en-Y gastric bypass (RYGB) oneanastomosis gastric bypass (OAGB), and, less commonly, after biliopancreatic diversion with duodenal switch (BPD/DS) or single anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S). Prevalence of MU after RYGB ranges from .6%-16%. This review summarizes the current knowledge about the treatment options available for MU after MBS for providers who treat them.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ASMBS literature review on the treatment of marginal ulcers after metabolic and bariatric surgery.\",\"authors\":\"R Wesley Vosburg, Abdelrahman Nimeri, Dan Azagury, Brandon Grover, Sabrena Noria, Pavlos Papasavas, Jonathan Carter\",\"doi\":\"10.1016/j.soard.2024.10.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Marginal ulcers (MUs) encompass a group of mucosal disruptions and subsequent inflammatory changes and their sequala found after Roux-en-Y gastric bypass (RYGB) oneanastomosis gastric bypass (OAGB), and, less commonly, after biliopancreatic diversion with duodenal switch (BPD/DS) or single anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S). Prevalence of MU after RYGB ranges from .6%-16%. This review summarizes the current knowledge about the treatment options available for MU after MBS for providers who treat them.</p>\",\"PeriodicalId\":94216,\"journal\":{\"name\":\"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.soard.2024.10.003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.soard.2024.10.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
边缘溃疡(MUs)包括一组粘膜破坏和随后的炎症性变化及其后遗症,可在 Roux-en-Y 胃旁路术(RYGB)、单吻合胃旁路术(OAGB)后发现,也可在胆胰转流术伴十二指肠转换术(BPD/DS)或单吻合十二指肠回肠造口术伴袖状胃切除术(SADI-S)后发现,但较少见。RYGB 术后 MU 的发病率在 0.6%-16% 之间。本综述总结了目前有关 MBS 后 MU 治疗方案的知识,供治疗 MU 的医疗人员参考。
ASMBS literature review on the treatment of marginal ulcers after metabolic and bariatric surgery.
Marginal ulcers (MUs) encompass a group of mucosal disruptions and subsequent inflammatory changes and their sequala found after Roux-en-Y gastric bypass (RYGB) oneanastomosis gastric bypass (OAGB), and, less commonly, after biliopancreatic diversion with duodenal switch (BPD/DS) or single anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S). Prevalence of MU after RYGB ranges from .6%-16%. This review summarizes the current knowledge about the treatment options available for MU after MBS for providers who treat them.